Evidence map›Paper›PMID 40335701›Full record

ArticleNature2025

PLA2G15 is a BMP hydrolase and its targeting ameliorates lysosomal disease.

Kwamina Nyame, Jian Xiong, Hisham N Alsohybe, Arthur P H de Jong, Isabelle V Peña, Ricardo de Miguel, Thijn R Brummelkamp, Guido Hartmann, Sebastian M B Nijman, Matthijs Raaben and 3 more

Abstract read
In one paragraph

Article in Nature, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 27 papers.

0numbers the graph read from it
0cells of the map it votes in
27citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

27 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. The Phospholipase AJournal of lipid and atherosclerosis · 2026
    Review
  5. Compartmental pH regulation in cancer and antitumor immunity: therapeutic opportunities and challenges.Apoptosis : an international journal on programmed cell death · 2026
    Review
  6. Article
  7. Review
  8. Article
  9. Article
  10. Vascular Aging.Circulation · 2026
    Review
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

13 authors.

Kwamina Nyame *Department of Chemical Engineering, Stanford University, Stanford, CA, USA.ORCID http://orcid.org/0000-0001-8898-4689
Jian Xiong *Department of Chemical Engineering, Stanford University, Stanford, CA, USA.ORCID http://orcid.org/0000-0001-9008-3134
Hisham N AlsohybeDepartment of Chemical Engineering, Stanford University, Stanford, CA, USA.ORCID http://orcid.org/0009-0002-3277-8821
Arthur P H de JongScenic Biotech, Science Park 301, Amsterdam, The Netherlands.ORCID http://orcid.org/0000-0002-7620-2704
Isabelle V PeñaDepartment of Chemical Engineering, Stanford University, Stanford, CA, USA.
Ricardo de MiguelPathology Department, AnaPath Services GmbH, Liestal, Switzerland.ORCID http://orcid.org/0000-0001-8732-9076
Thijn R BrummelkampScenic Biotech, Science Park 301, Amsterdam, The Netherlands.ORCID http://orcid.org/0000-0002-3066-7071
Guido HartmannScenic Biotech, Science Park 301, Amsterdam, The Netherlands.
Sebastian M B NijmanScenic Biotech, Science Park 301, Amsterdam, The Netherlands.ORCID http://orcid.org/0000-0003-0464-6661
Matthijs RaabenScenic Biotech, Science Park 301, Amsterdam, The Netherlands.
Judith A SimcoxHoward Hughes Medical Institute, Department of Biochemistry, University of Wisconsin-Madison, Madison, WI, USA.
Vincent A BlomenScenic Biotech, Science Park 301, Amsterdam, The Netherlands.
Monther Abu-RemailehDepartment of Chemical Engineering, Stanford University, Stanford, CA, USA. monther@stanford.edu.ORCID http://orcid.org/0000-0003-3772-0477

Funding

Innovations and mechanisms in tumor subcellular metabolismDP2CA271386 · NCI · STANFORD UNIVERSITY · PI ABU-REMAILEH, MONTHER · 2021 to 2024
$2.4M
Discovery and characterization of a novel acylcarnitine transporter in brown adipocytesR01DK133479 · NIDDK · UNIVERSITY OF WISCONSIN-MADISON · PI Judith Anne Simcox · 2022 to 2026
$1.5M
NCI NIH HHS DP2 CA271386NIDDK NIH HHS R01 DK133479
6 · The paper itself

Abstract

Lysosomes catabolize lipids and other biological molecules, maintaining cellular and organismal homeostasis. Bis(monoacylglycero)phosphate (BMP), a major lipid constituent of intralysosomal vesicles, stimulates lipid-degrading enzymes and is altered in various human conditions, including neurodegenerative diseases

Indexed as

HydrolasesLysophospholipidsLysosomal Storage DiseasesLysosomesMonoglyceridesAnimalsEsterificationFemaleHumansHydrolysisMaleMicebis(monoacylglyceryl)phosphateHydrolasesLysophospholipidsMonoglycerides

Identifiers

PMID40335701
PMCPMC12158761

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.